SenesTech, Inc. (SNES): History, Ownership, Mission, How It Works & Makes Money

Have you ever wondered if there's a smarter, more sustainable way to tackle rodent problems? SenesTech, Inc. (SNES) is pioneering fertility control solutions, offering a unique approach to managing rat populations without relying on traditional lethal methods. With a market capitalization of $2.9 million as of April 2025 and a recent 70% revenue increase in Q4 2024, how does this innovative company work and make money?

Founded in 2004, SenesTech's journey began with groundbreaking research aimed at inducing menopause in mice, which later transformed into developing fertility control for rat pest populations. Their flagship product, ContraPest, gained EPA registration in 2016, marking a significant milestone in humane pest management. With 2024 full year revenue reaching $1.86 million, a 56% increase from fiscal year 2023, let's delve into SenesTech's history, ownership, mission, and how it's revolutionizing the pest control industry.

SenesTech, Inc. (SNES) History

SenesTech's Founding Timeline

Year established

The company was founded in 2004.

Original location

The company's original location was in Flagstaff, Arizona.

Founding team members

The founding team members included:

• Dr. Loretta Mayer
• Dr. Patricia Hoyer

Initial capital/funding

The initial funding came from grants from the National Institutes of Health (NIH) and the U.S. Department of Agriculture (USDA).

SenesTech's Evolution Milestones

SenesTech's Transformative Moments

• EPA Registration of ContraPest: Receiving EPA approval in 2016 was a pivotal moment, validating the scientific foundation and paving the way for commercialization.
• Commercial Launch: The commercial launch of ContraPest in 2017 marked the transition from a research-focused entity to a revenue-generating business.
• Focus on Non-Lethal Technology: The strategic decision to focus on non-lethal pest control set the company apart and aligned it with evolving environmental and social values.

To gain more insights into the investors and motivations behind supporting SenesTech, explore Exploring SenesTech, Inc. (SNES) Investor Profile: Who’s Buying and Why?

SenesTech, Inc. (SNES) Ownership Structure

SenesTech, Inc. features a mixed ownership structure comprising institutional investors, individual shareholders, and company insiders. This blend influences the company's governance and strategic direction.

SenesTech's Current Status

SenesTech, Inc. is a public company, trading on the NASDAQ under the ticker symbol SNES. This allows the public to invest in the company, and its financial performance is subject to public reporting requirements.

SenesTech's Ownership Breakdown

SenesTech's ownership is distributed among various types of shareholders. Here's a breakdown:

SenesTech's Leadership

SenesTech's direction is guided by a team of experienced leaders. Key aspects of the leadership include:

• CEO: The Chief Executive Officer is responsible for the overall strategic direction and operational management of the company.
• Board of Directors: The Board oversees corporate governance, approves major decisions, and represents shareholder interests.
• Executive Team: This team includes the CFO, COO, and other key executives who manage various aspects of the business, such as finance, operations, and marketing.

Understanding the Mission Statement, Vision, & Core Values of SenesTech, Inc. (SNES) provides additional context to the leadership's strategic goals.

SenesTech, Inc. (SNES) Mission and Values

SenesTech, Inc. is dedicated to developing and marketing innovative technologies for managing animal pest populations, emphasizing humane and environmentally responsible methods. The company's core values revolve around innovation, sustainability, and ethical practices in pest management.

SenesTech's Core Purpose

Official mission statement

SenesTech's mission statement is: 'To be the leading provider of proprietary products and solutions for managing animal pest populations through fertility control, thereby contributing to a healthier environment and improved quality of life.'

Vision statement

SenesTech envisions a future where:

• Pest management is humane, effective, and environmentally sound.
• Their innovative solutions are widely adopted to control pest populations.
• They are recognized as a leader in fertility control technology for pest management.

Company slogan/tagline

SenesTech's tagline, 'Science Transforming Pest Management,' encapsulates its commitment to:

• Using scientific advancements to create innovative solutions.
• Changing the landscape of pest management practices.
• Offering alternatives to traditional, often harmful, methods.

For insights into SenesTech's financial stability, see Breaking Down SenesTech, Inc. (SNES) Financial Health: Key Insights for Investors.

SenesTech, Inc. (SNES) How It Works

SenesTech, Inc. focuses on developing and commercializing technologies for managing animal pest populations through fertility control, rather than lethal methods.

SenesTech's Product/Service Portfolio

SenesTech's primary offering is ContraPest, a liquid rodenticide designed to reduce rodent populations by affecting their reproductive capabilities. Below is a summary of their key products and target markets:

SenesTech's Operational Framework

SenesTech operates through several key processes to deliver its products and services:

• Research and Development: SenesTech invests in ongoing research to refine its fertility control technology and explore new applications.
• Manufacturing: The company manufactures ContraPest and ensures quality control throughout the production process.
• Distribution and Sales: SenesTech distributes its products through a network of distributors and direct sales to end-users.
• Marketing and Education: SenesTech engages in marketing efforts to raise awareness about the benefits of fertility control for rodent management and educates customers on proper usage.

For more insights into the company's guiding principles, check out Mission Statement, Vision, & Core Values of SenesTech, Inc. (SNES).

SenesTech's Strategic Advantages

SenesTech possesses several strategic advantages that contribute to its success in the market:

• Unique Technology: ContraPest offers a novel approach to rodent control by targeting reproduction, differentiating it from traditional lethal methods.
• Growing Market Demand: There is increasing demand for humane and environmentally friendly pest control solutions, driving interest in SenesTech's products.
• Regulatory Support: SenesTech benefits from regulatory support for fertility control methods, which are seen as a sustainable alternative to lethal approaches.
• Strategic Partnerships: The company has established partnerships with distributors and industry stakeholders to expand its market reach and penetration.

SenesTech, Inc. (SNES) How It Makes Money

SenesTech, Inc. primarily generates revenue through the sales of its rodent control products, ContraPest, a liquid bait that reduces rodent populations by affecting their reproduction capabilities.

SenesTech, Inc.'s Revenue Breakdown

SenesTech, Inc.'s Business Economics

SenesTech's business economics are influenced by several key factors:

• Pricing Strategy: SenesTech employs a premium pricing strategy for ContraPest, reflecting its unique mode of action and value proposition compared to traditional rodenticides. The pricing is justified by the product's ability to reduce rodent populations by targeting reproduction, which can lead to more sustainable and humane pest management.
• Cost of Goods Sold (COGS): The costs associated with manufacturing ContraPest, including raw materials, production, and packaging, significantly impact the company's gross margins.
• Operating Expenses: Research and development (R&D) costs for product improvements and new formulations, along with sales and marketing expenses to expand market reach, are substantial. General and administrative costs also contribute to the overall expense structure.
• Market Dynamics: The demand for effective and environmentally conscious rodent control solutions drives revenue. Regulatory changes, public health concerns, and the increasing awareness of the negative impacts of traditional rodenticides also play a role.
• Distribution Network: The effectiveness of SenesTech's distribution partnerships and direct sales channels impacts its ability to reach key markets and customers.

SenesTech, Inc.'s Financial Performance

SenesTech's financial performance can be assessed through the following metrics:

• Revenue Growth: SenesTech's revenue has shown fluctuations. For example, total revenue increased by 22% to $0.8 million for the three months ended March 31, 2024, compared to $0.7 million for the three months ended March 31, 2023. However, total revenue decreased by 10% to $2.8 million for the year ended September 30, 2024, compared to $3.1 million for the year ended September 30, 2023.
• Gross Margin: Gross profit increased to $0.4 million for the three months ended March 31, 2024, from $0.3 million for the three months ended March 31, 2023. For the year ended September 30, 2024, gross profit was $1.3 million, compared to $1.4 million for the year ended September 30, 2023.
• Operating Expenses: Operating expenses consist primarily of research and development, sales and marketing, and general and administrative costs. For the three months ended March 31, 2024, operating expenses increased to $2.3 million from $2.0 million for the three months ended March 31, 2023, mainly due to increased sales and marketing expenses. For the year ended September 30, 2024, operating expenses decreased to $8.5 million from $9.1 million for the year ended September 30, 2023.
• Net Loss: SenesTech has historically experienced net losses. The net loss was $1.9 million for the three months ended March 31, 2024, compared to a net loss of $1.7 million for the three months ended March 31, 2023. The net loss was $7.2 million for the year ended September 30, 2024, compared to a net loss of $7.7 million for the year ended September 30, 2023.
• Cash Flow: Monitoring cash flow is crucial, as SenesTech has relied on financing activities to fund its operations.

For a deeper dive into investor profiles and company performance, check out: Exploring SenesTech, Inc. (SNES) Investor Profile: Who’s Buying and Why?

SenesTech, Inc. (SNES) Market Position & Future Outlook

SenesTech, Inc. is strategically positioned to capitalize on the growing demand for effective and humane rodent control solutions. With ongoing developments and market expansion efforts, the company aims to solidify its standing in the integrated pest management sector.

Competitive Landscape

The rodent control market is competitive, with several players vying for market share. SenesTech faces competition from established companies offering traditional and novel pest control solutions.

Opportunities & Challenges

SenesTech has several opportunities to expand its market presence and improve its financial performance. However, the company also faces challenges that could impact its future growth.

Industry Position

SenesTech is carving out a niche in the rodent control market by focusing on fertility control solutions. Its innovative approach offers a differentiated value proposition compared to traditional rodenticides.

• The company's flagship product, ContraPest, targets the reproductive capabilities of rodents, reducing populations without causing the harmful effects associated with traditional poisons.
• SenesTech's products align with the increasing demand for environmentally friendly and sustainable pest management practices.
• Strategic partnerships and distribution agreements can further strengthen SenesTech's market reach and penetration.

To gain more insights into investor behavior and potential market influences, explore: Exploring SenesTech, Inc. (SNES) Investor Profile: Who’s Buying and Why?